Revenue: As of FY2025 Q3, the actual value is USD 4.657 M.EPS: As of FY2025 Q3, the actual value is USD -0.11.EBIT: As of FY2025 Q3, the actual value is USD -17.78 M.<h3>Segment Revenue</h3><ul><li>Products Revenue: $15.9 million for the nine months ended September 30, 2025, compared to $22.1 million for the same period in 2024, a decrease of $6.2 million or 28%.</li></ul><h3>Operational Metrics</h3><ul><li>Cost of Revenues: $15.4 million for the nine months ended September 30, 2025, compared to $21.7 million for the same period in 2024, a decrease of $6.2 million or 29%.</li><li>Research and Development Expenses: $9.9 million for the nine months ended September 30, 2025, compared to $15.3 million for the same period in 2024, a decrease of $5.4 million or 35%.</li><li>General and Administrative Expenses: $29.9 million for the nine months ended September 30, 2025, compared to $30.6 million for the same period in 2024, a decrease of $0.7 million or 2%.</li><li>Depreciation and Amortization: $8.3 million for the nine months ended September 30, 2025, compared to $7.9 million for the same period in 2024, an increase of $0.4 million or 5%.</li><li>Impairment of Assets: $16.8 million for the nine months ended September 30, 2025, compared to $15.2 million for the same period in 2024, an increase of $1.7 million or 11%.</li><li>Loss from Operations: $64.5 million for the nine months ended September 30, 2025, compared to $68.7 million for the same period in 2024, a decrease of $4.1 million or 6%.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: $23.9 million for the nine months ended September 30, 2025, compared to $45.1 million for the same period in 2024, a decrease of $21.2 million.</li><li>Net Cash Provided by Investing Activities: $7.9 million for the nine months ended September 30, 2025, compared to $19.5 million for the same period in 2024, a decrease of $11.6 million.</li><li>Net Cash Used in Provided by Financing Activities: - $6.0 million for the nine months ended September 30, 2025, compared to $3.5 million for the same period in 2024, a decrease of $9.5 million.</li></ul><h3>Unique Metrics</h3><ul><li>Investment Income: $3.2 million for the nine months ended September 30, 2025, compared to $5.4 million for the same period in 2024, a decrease of $2.2 million or 41%.</li><li>Gain in Fair Value of Common Stock Warrants Liability: $4.0 million gain for the nine months ended September 30, 2025, compared to - $2.9 million loss for the same period in 2024, an increase of $6.9 million.</li><li>Gain in Fair Value of Earnout Liability: $2.5 million gain for the nine months ended September 30, 2025, compared to - $2.4 million loss for the same period in 2024, an increase of $4.9 million.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company is focused on increasing PET closure production capacity and expanding PET closure technology into new product types and formats, and new packaging markets including food and home goods. Product development continues to progress as the company engages with technical, strategic, and supply chain partners.</li><li>Non-Core Business: The company is exploring strategic alternatives to maximize shareholder value, including a potential business combination, equity and debt financing, divestiture of assets, technology licensing, acquisition, merger, reverse merger, sale of assets, and other strategic arrangements including, potentially, sale of the company. The review is being overseen by the independent members of the Board of Directors, who are focused on strategic alternatives while management focuses on the development of the PET closures technology and business.</li></ul>

Origin Materials - CW26 | 10-Q: FY2025 Q3 Revenue: USD 4.657 M